1. Home
  2. CHCT vs VOGX Comparison

CHCT vs VOGX Comparison

Compare CHCT & VOGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Healthcare Trust Incorporated

CHCT

Community Healthcare Trust Incorporated

HOLD

Current Price

$14.93

Market Cap

514.6M

Sector

Real Estate

ML Signal

HOLD

VOGX

Vogenx Inc Common Stock

N/A

Current Price

$32.02

Market Cap

456.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHCT
VOGX
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
514.6M
456.5M
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
CHCT
VOGX
Price
$14.93
$32.02
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
359.4K
316.6K
Earning Date
05-05-2026
N/A
Dividend Yield
11.07%
N/A
EPS Growth
134.78
N/A
EPS
0.12
N/A
Revenue
$121,195,000.00
N/A
Revenue This Year
$9.06
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$125.17
N/A
Revenue Growth
4.67
N/A
52 Week Low
$13.23
$14.80
52 Week High
$19.17
$35.50

Technical Indicators

Market Signals
Indicator
CHCT
VOGX
Relative Strength Index (RSI) 35.36 100.00
Support Level $15.07 N/A
Resistance Level $16.09 N/A
Average True Range (ATR) 0.38 4.39
MACD 0.01 1.79
Stochastic Oscillator 50.67 86.39

Price Performance

Historical Comparison
CHCT
VOGX

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Share on Social Networks: